We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
In Vitro Activities of Ceftaroline/Avibactam, Ceftazidime/Avibactam, and Other Comparators Against Pathogens From Various Complicated Infections in China.
- Authors
Zhou, Menglan; Chen, Jingwei; Liu, Yali; Hu, Yunjian; Liu, Yingmei; Lu, Juan; Zhang, Shufang; Yu, Yunsong; Huang, Xun; Yang, Qing
- Abstract
Background We conducted a national antimicrobial surveillance study of both gram-positive and gram-negative organisms isolated from hospitalized patients. This report presents data on antimicrobial susceptibility among 4998 organisms collected in China between 2012 and 2014. Method The minimum inhibitory concentrations (MICs) and susceptibilities of ceftaroline/avibactam (CPA), ceftazidime/avibactam (CZA) and a range of comparative agents were determined according to guidelines established by the Clinical and Laboratory Standards Institute (CLSI). Results The highest overall susceptibility levels for all Enterobacteriaceae during the study period were observed for CPA, CZA, doripenem (DOR), meropenem (MEM), and amikacin (AMK), which were all >90%. However, both CPT and CAZ alone and in combination with avibactam showed low activities for Acinetobacter spp. whereas CPA and CZA exhibited MIC90values for Pseudomonas aeruginosa that were reduced by 4- and 8-fold, respectively, compared with those of CPT and CAZ. High susceptibilities of Acinetobacter spp. and P. aeruginosa to colistin and P. aeruginosa to AMK were observed. For the gram-positive strains, no significant activity changes were seen for Enterococcus, Staphylococcu s, and viridans group streptococci to CPT or CAZ alone or in combination with avibactam, whereas Streptococcus pneumoniae and β-hemolytic Streptococcus showed almost 100% susceptibility to both CPT and CPA. Conclusion The addition of 4 mg/L avibactam greatly increased the activities of CPT and CAZ against most Enterobacteriaceae and P. aeruginosa isolates, whereas no significant changes were observed in Acinetobacter spp. or any of the gram-positive strains.
- Subjects
CHINA; CEFTAROLINE; DRUG resistance in microorganisms; ENTEROBACTERIACEAE; GRAM-negative bacteria; GRAM-positive bacteria; HYDROLASES; MEDICAL protocols; MICROBIAL sensitivity tests; PSEUDOMONAS; PUBLIC health surveillance; CARBAPENEMS; VIRIDANS strepotococci; CEFTAZIDIME; GRAM-negative aerobic bacteria; IN vitro studies; AMIKACIN; MEROPENEM
- Publication
Clinical Infectious Diseases, 2018, Vol 67, pS206
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciy659